The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Biased agonism: An emerging paradigm in GPCR drug discovery
Open accessAbstract
G protein coupled receptors have historically been one of the most druggable classes of cellular proteins. The members of this large receptor gene family couple to primary effectors, G proteins, that have built in mechanisms for regeneration and amplification of signaling with each engagement of receptor and ligand, a kinetic event in itself. In recent years GPCRs, have been found to interact with arrestin proteins to initiate signal propagation in the absence of G protein interactions. This pinnacle observation has changed a previously held notion of the linear spectrum of GPCR efficacy and uncovered a new paradigm in GPCR research and drug discovery that relies on multidimensionality of GPCR signaling. Ligands were found that selectively confer activity in one pathway over another, and this phenomenon has been referred to as ‘biased agonism’ or ‘functional selectivity’. While great strides in the understanding of this phenomenon have been made in recent years, two critical questions still dominate the field: How can we rationally design biased GPCR ligands, and ultimately, which physiological responses are due to G protein versus arrestin interactions? This review will discuss the current understanding of some of the key aspects of biased signaling that are related to these questions, including mechanistic insights in the nature of biased signaling and methods for measuring ligand bias, as well as relevant examples of drug discovery applications and medicinal chemistry strategies that highlight the challenges and opportunities in this rapidly evolving field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Transduction of Receptor Signals by ß-Arrestins
Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
β-Arrestin-Dependent Formation of β 2 Adrenergic Receptor-Src Protein Kinase Complexes
Luttrell, L. M., Ferguson, S. S. G., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F.-T., Kawakatsu, H., Owada, K., Luttrell, D. K., et al. (1999) · Science · doi:10.1126/science.283.5402.655 · Cited by 1,475
β-Arrestin acts as a clathrin adaptor in endocytosis of the β2-adrenergic receptor
Goodman, O. B., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., & Benovic, J. L. (1996) · Nature · doi:10.1038/383447a0 · Cited by 1,384
The dynamin superfamily: universal membrane tubulation and fission molecules?
Praefcke, G. J. K., & McMahon, H. T. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1313 · Cited by 1,377
β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220
A MODIFICATION OF RECEPTOR THEORY
STEPHENSON, R. P. (1956) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1956.tb00006.x · Cited by 1,156
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077
Self-citationStructure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence
Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927
Self-citationTrends in the exploitation of novel drug targets
Rask-Andersen, M., Almén, M. S., & Schiöth, H. B. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3478 · Cited by 853
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O., Han, G. W., et al. (2015) · Nature · doi:10.1038/nature14656 · Cited by 807
The Dynamic Process of β2-Adrenergic Receptor Activation
Nygaard, R., Zou, Y., Dror, R. O., Mildorf, T. J., Arlow, D. H., Manglik, A., Pan, A. C., Liu, C. W., Fung, J. J., Bokoch, M. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.008 · Cited by 796
Salvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182234399 · Cited by 784
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Biased Signaling Pathways in β 2 -Adrenergic Receptor Characterized by 19 F-NMR
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., & Wüthrich, K. (2012) · Science · doi:10.1126/science.1215802 · Cited by 697
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
Half a century of antipsychotics and still a central role for dopamine D2 receptors
Kapur, S., & Mamo, D. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.004 · Cited by 638
The β 2 -adrenergic receptor/βarrestin complex recruits the clathrin adaptor AP-2 during endocytosis
Laporte, S. A., Oakley, R. H., Zhang, J., Holt, J. A., Ferguson, S. S. G., Caron, M. G., & Barak, L. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3712 · Cited by 635
Nobles, K. N., Xiao, K., Ahn, S., Shukla, A. K., Lam, C. M., Rajagopal, S., Strachan, R. T., Huang, T.-Y., Bressler, E. A., Hara, M. R., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001707 · Cited by 626
Morphine Side Effects in β-Arrestin 2 Knockout Mice
Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626
Self-citationβ-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C., & Lefkowitz, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912852107 · Cited by 600
Structural Basis for Molecular Recognition at Serotonin Receptors
Wang, C., Jiang, Y., Ma, J., Wu, H., Wacker, D., Katritch, V., Han, G. W., Liu, W., Huang, X.-P., Vardy, E., et al. (2013) · Science · doi:10.1126/science.1232807 · Cited by 528
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508
Functional Selectivity and Biased Receptor Signaling
Kenakin, T. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173948 · Cited by 505
Angiotensin II Type 1 Receptor Blockers
Burnier, M. (2001) · Circulation · doi:10.1161/01.cir.103.6.904 · Cited by 485
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A., & Novick, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200111m · Cited by 484
Benovic, J. L., Kühn, H., Weyand, I., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.8879 · Cited by 482
The structural basis of arrestin-mediated regulation of G-protein-coupled receptors
Gurevich, V. V., & Gurevich, E. V. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.008 · Cited by 472
Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide
Shukla, A. K., Manglik, A., Kruse, A. C., Xiao, K., Reis, R. I., Tseng, W.-C., Staus, D. P., Hilger, D., Uysal, S., Huang, L.-Y., et al. (2013) · Nature · doi:10.1038/nature12120 · Cited by 469
β-Adrenergic Receptor Kinase: Primary Structure Delineates a Multigene Family
Benovic, J. L., DeBlasi, A., Stone, W. C., Caron, M. G., & Lefkowitz, R. J. (1989) · Science · doi:10.1126/science.2552582 · Cited by 444
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
Shukla, A. K., Xiao, K., & Lefkowitz, R. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.003 · Cited by 418
Crystal Structure of β-Arrestin at 1.9 Å
Han, M., Gurevich, V. V., Vishnivetskiy, S. A., Sigler, P. B., & Schubert, C. (2001) · Structure · doi:10.1016/s0969-2126(01)00644-x · Cited by 397
Quantifying Ligand Bias at Seven-Transmembrane Receptors
Rajagopal, S., Ahn, S., Rominger, D. H., Gowen-MacDonald, W., Lam, C. M., DeWire, S. M., Violin, J. D., & Lefkowitz, R. J. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.072801 · Cited by 388
Violin, J. D., DeWire, S. M., Yamashita, D., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E. J., Gowen, M., & Lark, M. W. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173005 · Cited by 370
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
Biased ligands at G-protein-coupled receptors: promise and progress
Violin, J. D., Crombie, A. L., Soergel, D. G., & Lark, M. W. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.007 · Cited by 363
Allen, J. A., Yost, J. M., Setola, V., Chen, X., Sassano, M. F., Chen, M., Peterson, S., Yadav, P. N., Huang, X.-P., Feng, B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104807108 · Cited by 350
Kohout, T. A., Nicholas, S. L., Perry, S. J., Reinhart, G., Junger, S., & Struthers, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402125200 · Cited by 333
Masri, B., Salahpour, A., Didriksen, M., Ghisi, V., Beaulieu, J.-M., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803522105 · Cited by 320
Laugwitz, K. L., Allgeier, A., Offermanns, S., Spicher, K., Van Sande, J., Dumont, J. E., & Schultz, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.116 · Cited by 317
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
Lefkowitz, R. J., Rajagopal, K., & Whalen, E. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.007 · Cited by 301
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates κ-Opioid-Dependent Dysphoria
Bruchas, M. R., Land, B. B., Aita, M., Xu, M., Barot, S. K., Li, S., & Chavkin, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3769-07.2007 · Cited by 281
Zidar, D. A., Violin, J. D., Whalen, E. J., & Lefkowitz, R. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904361106 · Cited by 278
The Role of Gβγ Subunits in the Organization, Assembly, and Function of GPCR Signaling Complexes
Dupré, D. J., Robitaille, M., Rebois, R. V., & Hébert, T. E. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061008-103038 · Cited by 273
Energy Landscapes as a Tool to Integrate GPCR Structure, Dynamics, and Function
Deupi, X., & Kobilka, B. K. (2010) · Physiology · doi:10.1152/physiol.00002.2010 · Cited by 264
McPherson, J., Rivero, G., Baptist, M., Llorente, J., Al-Sabah, S., Krasel, C., Dewey, W. L., Bailey, C. P., Rosethorne, E. M., Charlton, S. J., et al. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066613 · Cited by 262
Bruchas, M. R., Macey, T. A., Lowe, J. D., & Chavkin, C. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513640200 · Cited by 258
Raehal, K. M., Schmid, C. L., Groer, C. E., & Bohn, L. M. (2011) · Pharmacological Reviews · doi:10.1124/pr.111.004598 · Cited by 256
Self-citationMultiple ligand-specific conformations of the β2-adrenergic receptor
Kahsai, A. W., Xiao, K., Rajagopal, S., Ahn, S., Shukla, A. K., Sun, J., Oas, T. G., & Lefkowitz, R. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.634 · Cited by 250
The Expanding Roles of Gβγ Subunits in G Protein–Coupled Receptor Signaling and Drug Action
Khan, S. M., Sleno, R., Gora, S., Zylbergold, P., Laverdure, J.-P., Labbé, J.-C., Miller, G. J., & Hébert, T. E. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005603 · Cited by 239
AKT Promotes rRNA Synthesis and Cooperates with c-MYC to Stimulate Ribosome Biogenesis in Cancer
Chan, J. C., Hannan, K. M., Riddell, K., Ng, P. Y., Peck, A., Lee, R. S., Hung, S., Astle, M. V., Bywater, M., Wall, M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001754 · Cited by 239
Holloway, A. C., Qian, H., Pipolo, L., Ziogas, J., Miura, S.-I., Karnik, S., Southwell, B. R., Lew, M. J., & Thomas, W. G. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12327-9 · Cited by 238
Structural flexibility of the Gαs α-helical domain in the β 2 -adrenoceptor Gs complex
Westfield, G. H., Rasmussen, S. G. F., Su, M., Dutta, S., DeVree, B. T., Chung, K. Y., Calinski, D., Velez-Ruiz, G., Oleskie, A. N., Pardon, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113645108 · Cited by 235
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
Shukla, A. K., Violin, J. D., Whalen, E. J., Gesty-Palmer, D., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804246105 · Cited by 231
Agonist-directed signaling of the serotonin 2A receptor depends on β-arrestin-2 interactions in vivo
Schmid, C. L., Raehal, K. M., & Bohn, L. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708862105 · Cited by 229
Self-citationGroer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., & Bohn, L. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028258 · Cited by 224
Self-citationWarne, T., Edwards, P. C., Leslie, A. G. W., & Tate, C. G. (2012) · Structure · doi:10.1016/j.str.2012.03.014 · Cited by 220
Rajagopal, K., Whalen, E. J., Violin, J. D., Stiber, J. A., Rosenberg, P. B., Premont, R. T., Coffman, T. M., Rockman, H. A., & Lefkowitz, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607583103 · Cited by 214
The Cubic Ternary Complex Receptor-Occupancy Model III. Resurrecting Efficacy
Weiss, J. M., Morgan, P. H., Lutz, M. W., & Kenakin, T. P. (1996) · Journal of Theoretical Biology · doi:10.1006/jtbi.1996.0139 · Cited by 212
Chen, X.-T., Pitis, P., Liu, G., Yuan, C., Gotchev, D., Cowan, C. L., Rominger, D. H., Koblish, M., DeWire, S. M., Crombie, A. L., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4010829 · Cited by 208
Viscusi, E. R., Webster, L., Kuss, M., Daniels, S., Bolognese, J. A., Zuckerman, S., Soergel, D. G., Subach, R. A., Cook, E., & Skobieranda, F. (2016) · Pain · doi:10.1097/j.pain.0000000000000363 · Cited by 205
Rahmeh, R., Damian, M., Cottet, M., Orcel, H., Mendre, C., Durroux, T., Sharma, K. S., Durand, G., Pucci, B., Trinquet, E., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201093109 · Cited by 196
Kang, D. S., Tian, X., & Benovic, J. L. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.11.005 · Cited by 191
Fulfilling the Promise of "Biased" G Protein–Coupled Receptor Agonism
Luttrell, L. M., Maudsley, S., & Bohn, L. M. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099630 · Cited by 190
Self-citationSeven-Transmembrane Receptor Signaling Through β-Arrestin
Shenoy, S. K., & Lefkowitz, R. J. (2005) · Science's STKE · doi:10.1126/stke.2005/308/cm10 · Cited by 189
Opioid receptor genes inactivated in mice: the highlights
Gavériaux-Ruff, C., & Kieffer, B. L. (2002) · Neuropeptides · doi:10.1054/npep.2002.0900 · Cited by 178
Schmid, C. L., & Bohn, L. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1665-10.2010 · Cited by 175
Self-citationCharest, P. G., Terrillon, S., & Bouvier, M. (2005) · EMBO reports · doi:10.1038/sj.embor.7400373 · Cited by 172
Bohn, L. M., Dykstra, L. A., Lefkowitz, R. J., Caron, M. G., & Barak, L. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.106 · Cited by 171
Self-citationTransfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11.
Offermanns, S., Wieland, T., Homann, D., Sandmann, J., Bombien, E., Spicher, K., Schultz, G., & Jakobs, K. H. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10203-4 · Cited by 170
Polypeptide variants of beta-arrestin and arrestin3
Sterne-Marr, R., Gurevich, V. V., Goldsmith, P., Bodine, R. C., Sanders, C., Donoso, L. A., & Benovic, J. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82304-3 · Cited by 162
Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors
Zhou, L., Lovell, K. M., Frankowski, K. J., Slauson, S. R., Phillips, A. M., Streicher, J. M., Stahl, E. L., Schmid, C. L., Hodder, P., Madoux, F., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.504381 · Cited by 158
Self-citationUbiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK Activation
Shenoy, S. K., Barak, L. S., Xiao, K., Ahn, S., Berthouze, M., Shukla, A. K., Luttrell, L. M., & Lefkowitz, R. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700852200 · Cited by 146
The Active Conformation of β-Arrestin1
Nobles, K. N., Guan, Z., Xiao, K., Oas, T. G., & Lefkowitz, R. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611483200 · Cited by 142
β-Arrestins and G Protein-Coupled Receptor Trafficking
Tian, X., Kang, D. S., & Benovic, J. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41199-1_9 · Cited by 142
Chen, X., Sassano, M. F., Zheng, L., Setola, V., Chen, M., Bai, X., Frye, S. V., Wetsel, W. C., Roth, B. L., & Jin, J. J. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300603y · Cited by 141
The biochemistry of the renin-angiotensin system and its role in hypertension
Skeggs, L. T., Dorer, F. E., Kahn, J. R., Lentz, K. E., & Levine, M. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90888-3 · Cited by 139
First Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Soergel, D. G., Subach, R. A., Sadler, B., Connell, J., Marion, A. S., Cowan, C. L., Violin, J. D., & Lark, M. W. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.207 · Cited by 134
β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury
Kim, K.-S., Abraham, D., Williams, B. Y., Violin, J. D., Mao, L., & Rockman, H. A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00475.2012 · Cited by 128
Griffin, M. T., Figueroa, K. W., Liller, S., & Ehlert, F. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.120857 · Cited by 123
Groer, C. E., Schmid, C. L., Jaeger, A. M., & Bohn, L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.248310 · Cited by 122
Self-citationZhang, J., Ferguson, S. S. G., Barak, L. S., Aber, M. J., Bruno Giros, A., Lefkowitz, R. J., & Caron, M. G. (1997) · PubMed · Cited by 116
Emerging structural insights into biased GPCR signaling
Shukla, A. K., Singh, G., & Ghosh, E. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.10.001 · Cited by 104
Pfleger, K. D. G., Dromey, J. R., Dalrymple, M. B., Lim, E. M. L., Thomas, W. G., & Eidne, K. A. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.01.004 · Cited by 102
Opiate Pharmacology and Relief of Pain
Pasternak, G. W. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.1079 · Cited by 102
Shonberg, J., Lopez, L., Scammells, P. J., Christopoulos, A., Capuano, B., & Lane, J. R. (2014) · Medicinal Research Reviews · doi:10.1002/med.21318 · Cited by 101
Gay, E. A., Urban, J. D., Nichols, D. E., Oxford, G. S., & Mailman, R. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.66.1.97 · Cited by 101
Sneddon, W. B., Magyar, C. E., Willick, G. E., Syme, C. A., Galbiati, F., Bisello, A., & Friedman, P. A. (2004) · Endocrinology · doi:10.1210/en.2003-1185 · Cited by 95
On the analysis of ligand-directed signaling at G protein-coupled receptors
Ehlert, F. J. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0260-4 · Cited by 94
A Structure–Activity Analysis of Biased Agonism at the Dopamine D2 Receptor
Shonberg, J., Herenbrink, C. K., López, L., Christopoulos, A., Scammells, P. J., Capuano, B., & Lane, J. R. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401318w · Cited by 91
Schmid, C. L., Streicher, J. M., Groer, C. E., Munro, T. A., Zhou, L., & Bohn, L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476234 · Cited by 89
Self-citationA Novel Method for Analyzing Extremely Biased Agonism at G Protein–Coupled Receptors
Stahl, E. L., Zhou, L., Ehlert, F. J., & Bohn, L. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.096503 · Cited by 80
Self-citationLin, Y., & Smrcka, A. V. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073072 · Cited by 77
Histidine 6.55 Is a Major Determinant of Ligand-Biased Signaling in Dopamine D2L Receptor
Tschammer, N., Bollinger, S., Kenakin, T., & Gmeiner, P. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.068106 · Cited by 77
Yang, C.-H., Huang, H.-W., Chen, K., Chen, Y.-S., Sheen‐Chen, S., & Lin, C. (2011) · British Journal of Anaesthesia · doi:10.1093/bja/aer291 · Cited by 75
Measurements of ligand bias and functional affinity
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954-c2 · Cited by 74
Alhaddad, H., Cisternino, S., Declèves, X., Tournier, N., Schlatter, J., Chiadmi, F., Risède, P., Smirnova, M., Besengez, C., Scherrmann, J., et al. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318265680a · Cited by 70
Molecular Mechanisms of Bitopic Ligand Engagement with the M1 Muscarinic Acetylcholine Receptor
Keov, P., López, L., Devine, S. M., Valant, C., Lane, J. R., Scammells, P. J., Sexton, P. M., & Christopoulos, A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582874 · Cited by 68
Lovell, K. M., Frankowski, K. J., Stahl, E. L., Slauson, S. R., Yoo, E., Prisinzano, T. E., Aubé, J., & Bohn, L. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00092 · Cited by 65
Self-citationBirnbaumer, L. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.027 · Cited by 63
Lamb, K. R., Tidgewell, K. J., Simpson, D. S., Bohn, L., & Prisinzano, T. E. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.10.026 · Cited by 63
Self-citationLefkowitz, R. J. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00001-2 · Cited by 62
Arrestins as Multi-Functional Signaling Adaptors
Gurevich, V. V., Gurevich, E. V., & Cleghorn, W. M. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_2 · Cited by 56
Li, Y.-T., Liu, X., Liu, C., Kang, J.-H., Yang, J.-Y., Pei, G., & Wu, C.-F. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10030954 · Cited by 55
Correll, C. C., & McKittrick, B. A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401677g · Cited by 54
True Arrestins and Arrestin-Fold Proteins
Aubry, L., & Klein, G. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00002-4 · Cited by 52
The potential for selective pharmacological therapies through biased receptor signaling
Kenakin, T. (2012) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-13-3 · Cited by 46
Brust, T. F., Hayes, M. P., Roman, D. L., & Watts, V. J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.10.014 · Cited by 40
Self-citationBrust, T. F., Hayes, M. P., Roman, D. L., Burris, K. D., & Watts, V. J. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220293 · Cited by 39
Self-citationA molecular basis for opiate action
Massotte, D., & Kieffer, B. L. (1998) · Essays in Biochemistry · doi:10.1042/bse0330065 · Cited by 37
Arrestin-Mediated Activation of p38 MAPK: Molecular Mechanisms and Behavioral Consequences
Chavkin, C., Schattauer, S. S., & Levin, J. R. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41199-1_14 · Cited by 26
Modeling G protein-coupled receptors in complex with biased agonists
Costanzi, S. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.04.004 · Cited by 9
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Sphingosine 1-phosphate: Lipid signaling in pathology and therapy
Cartier, A., & Hla, T. (2019) · Science · doi:10.1126/science.aar5551 · Cited by 613
Bias factor and therapeutic window correlate to predict safer opioid analgesics
Schmid, C. L., Kennedy, N. M., Ross, N. C., Lovell, K. M., Yue, Z., Morgenweck, J., Cameron, M. D., Bannister, T. D., & Bohn, L. M. (2017) · Cell · doi:10.1016/j.cell.2017.10.035 · Cited by 567
“…theory and practice is the concept that the structure of a GPCR ligand may be systematically modified to confer alternative receptor conformations upon binding, with each displaying a unique pattern of activation of intracellular signaling cascades (Rankovic et al., 2016; Urban et al., 2007).”
Structure of the neurotensin receptor 1 in complex with β-arrestin 1
Huang, W., Masureel, M., Qu, Q., Janetzko, J., Inoue, A., Kato, H. E., Robertson, M. J., Nguyen, K. C., Glenn, J. S., Skiniotis, G., et al. (2020) · Nature · doi:10.1038/s41586-020-1953-1 · Cited by 373
Váradi, A., Marrone, G. F., Palmer, T. C., Narayan, A., Szabó, M. R., Le Rouzic, V., Grinnell, S. G., Subrath, J. J., Warner, E., Kalra, S., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00748 · Cited by 323
Metadata
- Authors
- Rankovic, Z., Brust, T. F., & Bohn, L. M.
- Venue
- Bioorganic & Medicinal Chemistry Letters
- Publisher
- Elsevier BV
- Published
- 2016-01
- Volume
- 26
- Issue
- 2
- Pages
- 241-250
- ISSN
- 0960-894X (ISSN-L)
- OpenAlex
- W2191622804
- Cited by
- 282
- References
- 121
- FWCI
- 10.29
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.